23:12:48 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHandel & varor
IndustriDetaljhandel
Zinzino är verksamma inom hälsovård. Bolaget marknadsför och säljer produkter som berör en stor del områden som hudvård, immunsystem och viktnedsättning. Exempel på produkter som bolaget säljer inkluderar omega 3 och 6 olja, måltidsersättningar och kaffe. Zinzino innehar idag främst verksamhet inom Norden, Europa och Nordamerika. Huvudkontoret ligger i Västra Frölunda.

Kalender

2020-02-28 Bokslutskommuniké 2019
2019-11-15 Kvartalsrapport 2019-Q3
2019-08-30 Kvartalsrapport 2019-Q2
2019-05-23 Ordinarie utdelning ZZ B 0.50 SEK
2019-05-23 Bonusutdelning ZZ B 0.20 SEK
2019-05-22 Årsstämma 2018
2019-05-16 Kvartalsrapport 2019-Q1
2019-02-28 Bokslutskommuniké 2018
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-30 Kvartalsrapport 2018-Q2
2018-05-16 Ordinarie utdelning ZZ B 0.45 SEK
2018-05-15 Kvartalsrapport 2018-Q1
2018-05-15 Årsstämma 2017
2018-02-28 Bokslutskommuniké 2017
2017-11-13 Kvartalsrapport 2017-Q3
2017-08-31 Kvartalsrapport 2017-Q2
2017-05-26 Ordinarie utdelning ZZ B 0.25 SEK
2017-05-24 Årsstämma 2016
2017-05-10 Kvartalsrapport 2017-Q1
2017-02-28 Bokslutskommuniké 2016
2016-11-15 Kvartalsrapport 2016-Q3
2016-08-31 Kvartalsrapport 2016-Q2
2016-05-23 Ordinarie utdelning ZZ B 0.25 SEK
2016-05-20 Kvartalsrapport 2016-Q1
2016-05-20 Årsstämma 2015
2016-02-29 Bokslutskommuniké 2015
2015-11-23 Kvartalsrapport 2015-Q3
2015-08-31 Kvartalsrapport 2015-Q2
2015-05-22 Kvartalsrapport 2015-Q1
2015-05-06 Ordinarie utdelning ZZ B 0.25 SEK
2015-05-05 Årsstämma 2014
2015-02-27 Bokslutskommuniké 2014
2014-11-14 Kvartalsrapport 2014-Q3
2014-08-29 Kvartalsrapport 2014-Q2
2014-05-19 Ordinarie utdelning ZZ B 0.10 SEK
2014-05-16 Årsstämma 2013
2014-04-25 Kvartalsrapport 2014-Q1
2014-02-26 Bokslutskommuniké 2013
2013-10-25 Kvartalsrapport 2013-Q3
2013-08-31 Kvartalsrapport 2013-Q2
2013-06-13 Ordinarie utdelning ZZ B 0.00 SEK
2013-06-12 Årsstämma 2012
2013-04-25 Kvartalsrapport 2013-Q1
2013-02-28 Bokslutskommuniké 2012
2012-10-25 Kvartalsrapport 2012-Q3
2012-08-31 Kvartalsrapport 2012-Q2
2012-05-14 Kvartalsrapport 2012-Q1
2012-05-08 Årsstämma 2011
2012-02-28 Bokslutskommuniké 2011
2011-11-15 Kvartalsrapport 2011-Q3
2011-11-14 Extra Bolagsstämma 2011
2011-08-31 Kvartalsrapport 2011-Q2
2011-05-12 Kvartalsrapport 2011-Q1
2011-05-10 Ordinarie utdelning ZZ B 0.00 SEK
2011-05-09 Årsstämma 2010
2011-02-28 Bokslutskommuniké 2010
2019-08-13 15:15:00

Strong sales growth during July; Zinzino based revenue increased 47% and the total group revenue with a total of 44% compared with the previous year. 

The revenue in July for Zinzino's sales markets increased by 47% to MSEK 58.1 (39.6) due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 2% and amounted to MSEK 2.9 (2.8). Overall the Group increased revenues by 44% to MSEK 61.0 (42.4) compared with the previous year. 

Accumulated revenue for January - July 2019 increased by 25% MSEK 408.8 (327.2).  

Revenues distributed as follows: 

+--------------------+------+------+------+--------+--------+------+
|Regions,MSEK |19-jul|18-jul|Change|YTD 2019|YTD 2018|Change|
+--------------------+------+------+------+--------+--------+------+
|Baltic Markets | 4.1| 3.3| 26%| 30.0| 24.8| 21%|
+--------------------+------+------+------+--------+--------+------+
|Nordic Markets | 31.5| 27.8| 13%| 217.5| 213.3| 2%|
+--------------------+------+------+------+--------+--------+------+
|Europe Other Markets| 19.9| 6.7| 196%| 118.9| 40.7| 192%|
+--------------------+------+------+------+--------+--------+------+
|North America | 2.1| 1.8| 17%| 13.6| 11.7| 16%|
+--------------------+------+------+------+--------+--------+------+
|Australia | 0.5| 0.0| | 2.0| 0.0| |
+--------------------+------+------+------+--------+--------+------+
|Zinzino | 58.1| 39.6| 47%| 382.0| 290.4| 32%|
+--------------------+------+------+------+--------+--------+------+
|Faun Pharma | 2.9| 2.8| 2%| 26.8| 36.8| -27%|
+--------------------+------+------+------+--------+--------+------+
|Zinzino Group | 61.0| 42.4| 44%| 408.8| 327.2| 25%|
+--------------------+------+------+------+--------+--------+------+

The sales figures are prepared according to IFRS. Adjustment for IFRS 15, income from customers has affected comparative figures.

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se 

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 15:15 the 13th of August 2019.

Zinzino AB (publ.) is a direct sales company that operates throughout Europe, North America and Australia. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns the Norwegian company BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has more than 120 employees and currently trades in 34 markets across Europe, North America and Australia. Zinzino is based in Gothenburg, with additional offices in Helsinki, Riga, Oslo, Florida and Brisbane. Zinzino is a public company listed on Nasdaq First North.